Expertise in
2
conditions

Ainara Soria

Ciberonc
La Paz, MD, ES 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Ciberonc
La Paz, MD, ES 

Overview

Ainara Soria practices practicing medicine in La Paz, Spain.

Ms. Soria is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Adenoid Cystic Carcinoma, Reflux Nephropathy, and Gastrostomy.

She is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

CIBERONC
La Paz, MD, Spain
Other Locations
Madrid, MD, Spain
Barcelona, CT 08950, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Enrollment Status: Recruiting
Publish Date: April 04, 2025
Intervention Type: Other
Phase II, Multicentre Clinical Trial to Evaluate the Activity of Encorafenib and Binimetinib Administered Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
Phase II, Multicentre Clinical Trial to Evaluate the Activity of Encorafenib and Binimetinib Administered Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
Enrollment Status: Completed
Publish Date: May 21, 2025
Intervention Type: Drug, Radiation
Study Drugs: Encorafenib, Binimetinib
Study Phase: Phase 2
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: IRX-2, Cyclophosphamide, Indomethacin, Omeprazole
Study Phase: Phase 2
A Randomized Phase 3 Comparison of IMO-2125 With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
A Randomized Phase 3 Comparison of IMO-2125 With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drugs: Ipilimumab, IMO-2125
Study Phase: Phase 3
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ADU-1604, an Anti-CTLA-4 Antibody, in Adults With Metastatic Melanoma
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ADU-1604, an Anti-CTLA-4 Antibody, in Adults With Metastatic Melanoma
Enrollment Status: Terminated
Publish Date: May 26, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

35 Total Publications

Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801.
Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 06, 2025

Frequently Asked Questions about Ainara Soria

Is Ainara Soria a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Ainara Soria is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ainara Soria participate in research or clinical trials?

Yes. Ainara Soria has published 35 articles and abstracts on conditions like Melanoma. You can view a list of Ainara Soria's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Soria's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile